HIGHLIGHTS
- who: Florent Allagnat from the Department of Vascular Surgery, Lausanne University, Lausanne, Switzerland, Department of Biomedical have published the research work: Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia, in the Journal: (JOURNAL)
- future: Clearly further work is required to better characterize the cells composing the neointima layer in patients. Discussion NEW PERSPECTIVES FOR THE TREATMENT OF INTIMAL HPERPLASIA USING HYDROGEN SULFIDE-BASED THERAPIES There is currently no clinically approved molecule exploiting the clinical potential of H2 S. Most compounds available for research have poor translational potential due to their pharmacokinetic properties.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.